| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 05/14/2009 | WO2009039986A3 Use of the peptide asn-asp-asp-cys-glu- leu-cys-val-asn-val-ala-cys-thr-gly-cys-leu alone or in combination with the peptide thr-thr-ser-gln-val- arg-pro-αrg as a therapeutic agent |
| 05/14/2009 | WO2009037357A4 Benzimidazole nf- kappab inhibitors |
| 05/14/2009 | WO2009033807A3 Therapeutic uses of b-type natriuretic peptide and human growth hormone 1-43 |
| 05/14/2009 | WO2009033804A3 Use of gamma- endorphin as a therapeutic agent |
| 05/14/2009 | WO2009033803A3 Use of the pentapeptide drlds and gamma-endorphin as therapeutic agents |
| 05/14/2009 | WO2009033799A3 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2009033754A8 Use of a peptide as a therapeutic agent |
| 05/14/2009 | WO2008041236A3 Composition comprising crustacean gastrolith components, calcium carbonate and its use |
| 05/14/2009 | US20090124704 Therapeutic foam |
| 05/14/2009 | US20090124682 Indan-Amide Derivatives with Glycogen Phosphorylase Inhibitory Activity |
| 05/14/2009 | US20090124674 Method for treating congestive heart failure |
| 05/14/2009 | US20090124673 Method for treating diabetic nephropathy |
| 05/14/2009 | US20090124668 Cyclic derivatives as modulators of chemokine receptor activity |
| 05/14/2009 | US20090124665 Potassium Channel Inhibitors |
| 05/14/2009 | US20090124664 (R)-Arylalkylamino Derivatives and Pharmaceutical Compositions Containing Them |
| 05/14/2009 | US20090124660 Piperidine Compounds Useful as Malonyl-CoA Decarboxylase Inhibitors |
| 05/14/2009 | US20090124654 Aryl and Heteroaryl Compounds, Compositions, Methods of Use |
| 05/14/2009 | US20090124649 Aza spiro alkane derivatives as inhibitors of metalloproteases |
| 05/14/2009 | US20090124645 Novel Pyrimidine-2,4-Diamine Derivatives and their Use as Modulators of Small-Conductance Calcium-Activated Potassium Channels |
| 05/14/2009 | US20090124638 Anti-inflammatory pyrazolopyrimidines |
| 05/14/2009 | US20090124617 Quinolone derivative or salt thereof |
| 05/14/2009 | US20090124614 Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1 receptor mediated disorders |
| 05/14/2009 | US20090124604 4-oxoquinazolin-3-yl benzamide derivatives for the treatment of cytokine diseases |
| 05/14/2009 | US20090124581 Novel phosphonic acid compounds as inhibitors of serine proteases |
| 05/14/2009 | US20090124555 Use of histogranin and histogranin-like compounds as inhibitors of p2x7 receptor function and as anti-arthritic agents |
| 05/14/2009 | US20090124537 Screening method for bone morphogenetic mimetics |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123566 Use of a phosphate adsorbent to combat vascular diseases |
| 05/14/2009 | US20090123565 Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto |
| 05/14/2009 | US20090123543 Pharmaceutical compositions |
| 05/14/2009 | US20090123538 Angiotensin II Receptor Antagonists |
| 05/14/2009 | US20090123516 Drug delivery from implants using self-assembled monolayers-therapeutic sams |
| 05/14/2009 | US20090123465 Assessment of cardiac health and thrombotic risk in a patient |
| 05/14/2009 | US20090123462 Fgfr agonists |
| 05/14/2009 | US20090123452 Protease screening methods and proteases identified thereby |
| 05/14/2009 | US20090123440 using gutless adenovirus vector; gene therapy; gutless means incapable of expressing any adenovirus antigens; atherosclerosis |
| 05/14/2009 | US20090123435 Cultured three-dimensional tissues and uses thereof |
| 05/14/2009 | US20090123433 Compositions Comprising Human Embryonic Stem Cells and their Derivatives, Methods of Use, and Methods of Preparation |
| 05/14/2009 | US20090123415 Diagnosis, treatment, and prevention of vascular disorders using il-1 autoantibodies |
| 05/14/2009 | US20090123412 Methods and compositions for stabilizing the myocardium |
| 05/14/2009 | US20090123379 Novel screens to identify agents that modulate retinal blood vessel function and pericyte function and diagnostic and therapeutic application therefor |
| 05/14/2009 | DE212007000063U1 Feste Arzneiform von Olmesartan Medoxomil und Amlodipin Solid dosage form of olmesartan medoxomil and amlodipine |
| 05/14/2009 | DE10163130B4 Apoptotisch wirksame Peptide und diese umfassende pharmazeutische Zusammensetzungen Apoptotic active peptides and pharmaceutical compositions comprising |
| 05/14/2009 | CA2705316A1 Modulation of factor 7 expression |
| 05/14/2009 | CA2704663A1 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 05/14/2009 | CA2704222A1 Cyclic urea inhibitors of 11.beta.-hydroxysteroid dehydrogenase 1 |
| 05/14/2009 | CA2703099A1 Activin receptor-like kinase-i compositions and methods of use |
| 05/13/2009 | EP2058658A2 Method and means for influencing intercellular communication and intercellular organelle transport |
| 05/13/2009 | EP2058333A2 Anti-CCR2 antibodies and methods of use therefor |
| 05/13/2009 | EP2058332A1 Use of CD25 binding molecules in steroid-resistant patients |
| 05/13/2009 | EP2058317A1 Aminophosphoric acid ester derivative and s1p receptor modulator containing the same as active ingredient |
| 05/13/2009 | EP2058310A1 Pyrazolopyridine carboxamide derivative and phosphodiesterase (pde) inhibitor comprising the derivative |
| 05/13/2009 | EP2058309A1 Fused heterocyclic compound |
| 05/13/2009 | EP2058305A1 Urea derivative |
| 05/13/2009 | EP2058302A1 Method for producing phenoxypyridine derivative |
| 05/13/2009 | EP2058293A1 Lipoxin compounds and their use in treating cell proliferative disorders |
| 05/13/2009 | EP2057990A1 Lipid metabolism improving agent containing hydrogen molecule |
| 05/13/2009 | EP2057987A1 Pharmaceutical composition containing statin-encapsulated nanoparticle |
| 05/13/2009 | EP2057985A1 Coated tablet |
| 05/13/2009 | EP2057905A1 Composition for moderating Triglyceride and Cholesterol Levels |
| 05/13/2009 | EP2057170A2 Polymorphic forms of spirapril hydrochloride |
| 05/13/2009 | EP2057163A1 Fused imidazole derivatives for the treatment of disorders mediated by aldosterone synthase and/or 11-beta-hydroxylase and/or aromatase |
| 05/13/2009 | EP2057122A1 Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the 2 adrenergic receptor |
| 05/13/2009 | EP2056882A2 Identification of a micro-rna that activates expression of beta-myosin heavy chain |
| 05/13/2009 | EP2056856A2 Use of tenecteplase for treating acute ischemic stroke |
| 05/13/2009 | EP2056851A1 Organ preservation and/or perfusion |
| 05/13/2009 | EP2056830A1 Compositions useful especially for treatment or prevention of metabolic syndrome |
| 05/13/2009 | EP2056806A2 Use of certain chemical compounds for the inhibition of the peptidyl-prolyl cis/trans isomerase activity of cyclophilins |
| 05/13/2009 | EP2056802A2 Anti-diabetes composition containing chicoric acid and/or one of the metabolites thereof |
| 05/13/2009 | EP1721610B1 Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 05/13/2009 | EP1655028B1 Use of cyclic bioisosteres of purine system derivatives for the treatment of diseases caused by disorders of nitrergic and dopaminergic systems |
| 05/13/2009 | EP1397356B1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 05/13/2009 | EP1377570B1 Substituted 2-carba-3,5-dicyano-4-aryl-6-aminopyridines and the use of the same as selective ligands of the adenosine receptor |
| 05/13/2009 | EP1305026B1 Barbituric acid analogs as therapeutic agents |
| 05/13/2009 | EP1259474B1 Calcium dicarboxylate ethers, methods of making same |
| 05/13/2009 | EP1232252B1 Reversibly inactivated acidified plasmin |
| 05/13/2009 | EP0934311B1 New heterocyclylmethyl-substituted pyrazol derivates |
| 05/13/2009 | CN101432014A Cathepsin propeptide and uses thereof |
| 05/13/2009 | CN101431998A Pharmaceutical compositions comprising CBx cannabinoid receptor modulators and potassium channel modulators |
| 05/13/2009 | CN101431993A Use of DHA and ARA in the preparation of a composition for regulating gene expression |
| 05/13/2009 | CN101429497A In vitro cultivation method Olfactory stem cell |
| 05/13/2009 | CN101429483A Cultivation method for silkworm chrysalis cordyceps sinensis and capsule thereof |
| 05/13/2009 | CN101429239A Anti-atherosis epitope composition, preparation method and uses thereof |
| 05/13/2009 | CN101429231A Antihypertensive active kyrine, preparation and uses thereof |
| 05/13/2009 | CN101429200A Tricyclic benzopyran compound as anti-arrhythmic agents |
| 05/13/2009 | CN101429185A Two-crystal type of substance of meletin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101429184A Two-crystal type of substance of luteolin, production method, medicament composition and uses thereof |
| 05/13/2009 | CN101428133A Method of preparing pellet for dispelling nine cardiodynias |
| 05/13/2009 | CN101428117A Medicament for invigorating pulse and reducing adipose, and preparation method thereof |
| 05/13/2009 | CN101428110A Hypolipemic capsule of ginseng |
| 05/13/2009 | CN101428109A Medicament composition for treating piles and method of preparing the same |
| 05/13/2009 | CN101428094A Uses of medicament composition in preparing medicament for improving brain microcirculation disorder |
| 05/13/2009 | CN101428093A Uses of medicament composition in preparing medicament for inhibiting albumin leakage |
| 05/13/2009 | CN101428092A Uses of Chinese medicinal composition in preparing medicament for inhibiting leukocyte |
| 05/13/2009 | CN101428091A Uses of medicament in preparing medicament for inhibiting of peroxide |
| 05/13/2009 | CN101428081A Liquid for indolence treatment of internal/external hemorrhoid |
| 05/13/2009 | CN101428068A Method for purifying ficus microcarpa leaf flavonoid compound with large-hole adsorption resin |
| 05/13/2009 | CN101428050A Active composition for treating thrombus, cardio-cerebrovascular system diseases |
| 05/13/2009 | CN101428041A Cordyceps sinensis extract, preparation method and uses in preparing medicament |
| 05/13/2009 | CN101428031A Medicament preparation for preventing cardiovascular diseases |